Global Pilar Cyst Treatment Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2032

Pilar Cyst Treatment Market Size

• The global pilar cyst treatment market size was valued at USD 70.50 million in 2024 and is expected to reach USD 106.56 million by 2032, at a CAGR of 5.30% during the forecast period
• The market growth is largely fueled by increasing awareness about dermatological conditions, advancements in medical technology, and a rising prevalence of pilar cysts, which are common benign scalp growths
• Furthermore, growing demand for minimally invasive and effective treatment options in hospitals, dermatology clinics, and specialty centers is positioning pilar cyst treatments as a preferred therapeutic solution. These converging factors are accelerating the adoption of treatment solutions, thereby significantly boosting the industry's growth

Pilar Cyst Treatment Market Analysis

• Pilar cyst treatments, including medications and medical devices, are increasingly essential for managing benign scalp growths due to their effectiveness, minimal invasiveness, and low recurrence rates, making them a preferred choice in both hospital and clinic settings
• The escalating demand for pilar cyst treatments is primarily fueled by rising awareness of dermatological conditions, increasing patient preference for safe and effective therapies, and advancements in medications and devices that improve recovery outcomes
• North America dominated the pilar cyst treatment market with the largest revenue share of 41% in 2024, driven by high healthcare spending, advanced medical infrastructure, and a strong presence of key dermatology clinics and hospitals. The U.S. particularly witnessed substantial adoption of advanced treatment options, supported by clinical innovations and growing patient awareness
• Asia-Pacific is expected to be the fastest-growing region in the pilar cyst treatment market during the forecast period due to increasing healthcare access, rising disposable incomes, and growing awareness of dermatological treatments
• Medication segment dominated the pilar cyst treatment market with a market share of 52.8% in 2024, driven by its widespread accessibility, ease of use, and strong adoption across hospitals, specialty clinics, and dermatology centers

Report Scope and Pilar Cyst Treatment Market Segmentation

Pilar Cyst Treatment Market Trends

Advancements in Minimally Invasive Treatments

• A significant and accelerating trend in the global pilar cyst treatment market is the growing adoption of minimally invasive procedures, such as laser-assisted excision and device-aided removal, which reduce recovery time and scarring
  • For instance, dermatology clinics increasingly use radiofrequency and laser devices to remove pilar cysts with precision, offering patients faster healing and improved cosmetic outcomes
• Integration of advanced imaging and diagnostic tools allows practitioners to accurately locate cysts and plan precise removal, minimizing tissue damage and recurrence
• These technological advancements are reshaping patient expectations, emphasizing treatments that combine effectiveness with minimal discomfort and downtime
• Companies and clinics are now developing device-assisted protocols that complement medications, enhancing overall treatment success and patient satisfaction
• The demand for innovative, less invasive, and patient-friendly pilar cyst treatments is growing rapidly across hospitals and specialty clinics, driven by awareness and preference for modern dermatological solutions

Pilar Cyst Treatment Market Dynamics

Driver

Rising Awareness of Dermatological Conditions and Demand for Effective Therapies

• The increasing awareness of scalp and skin health, combined with the need for safe and effective treatment options, is a major driver for the pilar cyst treatment market
  • For instance, clinics are conducting educational campaigns and online consultations to inform patients about early diagnosis and treatment benefits, boosting treatment adoption
• Patients increasingly prefer treatments that reduce recurrence and minimize scarring, driving demand for both medications and device-assisted solutions
• The expansion of specialty clinics and dermatology centers is facilitating greater access to advanced treatment options, accelerating market growth
• Availability of medications and devices through multiple channels, including hospitals and retail pharmacies, further supports the uptake of pilar cyst treatments
• Convenience, effectiveness, and minimally invasive approaches are key factors propelling adoption in both developed and emerging regions

Restraint/Challenge

Limited Access to Specialized Dermatological Care and Treatment Costs

• Limited availability of trained dermatologists and specialized clinics in certain regions poses a significant challenge to market growth
  • For instance, patients in rural or underserved areas often face delayed treatment or rely on over-the-counter medications, reducing effective market penetration
• High costs associated with device-assisted procedures or advanced medications can restrict adoption, particularly in price-sensitive markets
• Insurance coverage limitations for dermatological procedures may further hinder access to optimal treatments for pilar cysts
• While awareness is increasing, the lack of standard treatment protocols and regional variations in medical infrastructure can slow widespread adoption
• Addressing these challenges through training programs, cost-effective solutions, and teledermatology initiatives will be crucial for sustained market growth

Pilar Cyst Treatment Market Scope

The market is segmented on the basis of treatment type, end-users, and distribution channel.

• By Treatment Type

On the basis of treatment type, the pilar cyst treatment market is segmented into medication and devices. The medication segment dominated the market with the largest market revenue share of 52.8% in 2024, driven by its widespread availability, ease of use, and lower procedural risk compared to surgical interventions. Patients and dermatologists often prioritize medication-based treatments for small or early-stage cysts due to their convenience, non-invasive nature, and reduced recovery time. Medications also enable home-based management in certain cases, making them highly accessible and cost-effective. The market sees strong demand for medications because of their integration with complementary therapies and increasing patient awareness about scalp and skin health. Pharmaceutical advancements improving formulation efficacy further boost adoption. Overall, the segment benefits from high penetration in hospitals, specialty clinics, and retail pharmacies.

The device segment is anticipated to witness the fastest growth rate during the forecast period, fueled by the rising adoption of minimally invasive removal technologies and advanced dermatological equipment. Devices such as laser-assisted excision tools, radiofrequency devices, and precision surgical instruments allow dermatologists to treat pilar cysts efficiently with lower recurrence rates. Hospitals and specialty clinics increasingly prefer device-assisted treatments due to faster procedure times, improved patient satisfaction, and enhanced clinical outcomes. The aesthetic and cosmetic benefits offered by device-assisted procedures also contribute to market growth. Growing investments in R&D and rising awareness among patients for advanced treatments further support the rapid adoption of device-based solutions.

• By End-Users

On the basis of end-users, the pilar cyst treatment market is segmented into specialty clinics, hospitals, dermatology clinics, ambulatory surgical centers, home healthcare, and others. The specialty clinics segment dominated the market in 2024, accounting for the largest revenue share, due to their focus on dermatology and cosmetic procedures. Specialty clinics offer tailored treatment plans, access to trained dermatologists, and advanced procedural facilities, making them a preferred choice for patients seeking effective and convenient pilar cyst management. The market is supported by the increasing number of specialty clinics, growing patient awareness, and availability of medication and device-based treatment options in these facilities. Moreover, the flexible consultation schedules and personalized care models offered by specialty clinics enhance patient satisfaction and repeat visits. The high adoption rate of minimally invasive procedures in specialty clinics further reinforces their market dominance.

The home healthcare segment is expected to witness the fastest growth during the forecast period, driven by rising demand for convenient, remote, and non-invasive treatment options that can be administered at home under professional guidance. Medications, topical therapies, and remote monitoring devices allow patients to manage early-stage pilar cysts without frequent hospital visits. Growth in home healthcare is also fueled by increasing telemedicine adoption, awareness campaigns about scalp and skin health, and preference for privacy and comfort during treatment. The segment benefits from collaborations between dermatologists and home healthcare providers, enabling prescription-based treatments and virtual follow-ups. As patients increasingly seek cost-effective and flexible treatment options, home healthcare adoption continues to accelerate.

• By Distribution Channel

On the basis of distribution channel, the pilar cyst treatment market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others. The hospital pharmacy segment dominated the market in 2024 due to direct access to patients receiving treatment within healthcare facilities. Hospital pharmacies ensure timely availability of prescribed medications and device-assisted treatment accessories, supporting efficient treatment workflows. They also allow dermatologists to monitor patient adherence, adjust dosages, and provide professional guidance, enhancing treatment outcomes. The segment benefits from strong trust in hospital-based services and established procurement networks. The convenience, reliability, and professional supervision offered by hospital pharmacies sustain their leadership in the market.

The online pharmacy segment is expected to witness the fastest growth during the forecast period, driven by rising e-commerce adoption, convenience of doorstep delivery, and increasing awareness of scalp and skin care. Patients prefer online platforms for discreet purchases, access to a wide range of medications, and the ability to compare brands and prices. Growth is further accelerated by teledermatology services recommending treatments that can be procured online. The segment benefits from digital payment adoption, rapid logistics networks, and patient preference for flexible treatment procurement, making online pharmacies a rapidly expanding channel in the pilar cyst treatment market.

Pilar Cyst Treatment Market Regional Analysis

• North America dominated the pilar cyst treatment market with the largest revenue share of 41% in 2024, driven by high healthcare spending, advanced medical infrastructure, and a strong presence of key dermatology clinics and hospitals
• Patients and healthcare providers in the region highly value the availability of effective medications and advanced device-assisted treatments, as well as the quality of professional dermatological care provided in hospitals and specialty clinics
• This widespread adoption is further supported by high awareness of scalp and skin health, growing prevalence of dermatological conditions, and increasing patient preference for minimally invasive and reliable treatment options, establishing pilar cyst treatments as the preferred solution across both hospital and clinic settings

U.S. Pilar Cyst Treatment Market Insight

The U.S. pilar cyst treatment market captured the largest revenue share in North America in 2024, driven by the high prevalence of dermatological conditions and increasing awareness of scalp and skin health. Patients are increasingly prioritizing minimally invasive and effective treatment options, including medications and device-assisted procedures. The growing adoption of advanced dermatology clinics and specialty centers, combined with teledermatology services, further propels the market. Moreover, the integration of innovative treatment devices and advanced medications is significantly contributing to better outcomes and patient satisfaction. The strong healthcare infrastructure and high disposable income of patients also support widespread treatment adoption.

Europe Pilar Cyst Treatment Market Insight

The Europe pilar cyst treatment market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by the rising demand for cosmetic and minimally invasive dermatological procedures. Increasing awareness of scalp and skin conditions, coupled with a growing number of specialty clinics and hospitals offering advanced treatment options, is fostering adoption. European patients are also drawn to treatment solutions that reduce recovery time and minimize scarring. The market is experiencing growth across hospitals, dermatology clinics, and ambulatory surgical centers, with pilar cyst treatments being integrated into routine dermatological care.

U.K. Pilar Cyst Treatment Market Insight

The U.K. pilar cyst treatment market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by the rising focus on cosmetic and scalp health, along with a desire for minimally invasive and effective therapies. In addition, the growing awareness of early diagnosis and treatment benefits is encouraging both patients and dermatologists to opt for medications and device-assisted procedures. The U.K.’s strong healthcare infrastructure, coupled with widespread adoption of teledermatology and dermatology clinics, is expected to continue to stimulate market growth.

Germany Pilar Cyst Treatment Market Insight

The Germany pilar cyst treatment market is expected to expand at a considerable CAGR during the forecast period, fueled by increasing awareness of dermatological conditions and rising demand for advanced, patient-friendly treatments. Germany’s well-developed healthcare infrastructure, combined with a focus on innovation and high-quality care, promotes the adoption of medications and device-assisted procedures. Hospitals and specialty clinics are increasingly offering minimally invasive treatment options, while patients prefer solutions that reduce recovery time and recurrence risk. The emphasis on cosmetic outcomes and patient satisfaction aligns with local consumer expectations, supporting market growth.

Asia-Pacific Pilar Cyst Treatment Market Insight

The Asia-Pacific pilar cyst treatment market is poised to grow at the fastest CAGR during the forecast period, driven by increasing urbanization, rising disposable incomes, and greater healthcare access in countries such as China, Japan, and India. The region’s growing awareness of dermatological health and cosmetic concerns is driving the adoption of medications and device-assisted treatments. Government initiatives promoting healthcare infrastructure and telemedicine are further supporting market growth. Moreover, expanding specialty clinics and hospitals, along with affordability and accessibility of treatments, are increasing patient uptake across residential and clinical settings.

Japan Pilar Cyst Treatment Market Insight

The Japan pilar cyst treatment market is gaining momentum due to the country’s technologically advanced healthcare system, increasing awareness of dermatological conditions, and demand for minimally invasive treatments. Patients in Japan emphasize early diagnosis, cosmetic outcomes, and convenience, fueling the adoption of both medications and device-assisted procedures. Integration with teledermatology services and home-based care is also supporting market growth. Furthermore, Japan’s aging population is such asly to spur demand for simpler, safer, and effective treatment options in both residential and clinical settings.

India Pilar Cyst Treatment Market Insight

The India pilar cyst treatment market accounted for the largest market revenue share in Asia-Pacific in 2024, attributed to the country’s expanding middle class, rapid urbanization, and increasing healthcare awareness. India is witnessing growing adoption of medications and minimally invasive device-assisted procedures across hospitals, dermatology clinics, and specialty centers. Government healthcare initiatives and the expansion of teledermatology services are facilitating wider access to treatments. In addition, the availability of cost-effective solutions and strong domestic manufacturers are key factors propelling market growth in India.

Pilar Cyst Treatment Market Share

The Pilar Cyst Treatment industry is primarily led by well-established companies, including:

• Centrient Pharmaceuticals Netherlands B.V. (Netherlands)
• Sandoz Group AG (Switzerland)
• Fresenius Kabi AG (Germany)
• Aurobindo Pharma Limited (India)
• Fuan Pharmaceutical (Group) Co., Ltd. (China)
• Penam Laboratories Ltd. (India)
• ACS Dobfar (Italy)
• Kaliberr Labs (India)
• Lupin (U.S.)
• Teva Pharmaceutical Industries Ltd. (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Unimark Remedies Limited. (India)
• YUNGSHIN PHARM IND. CO. LTD (Taiwan)
• Hovione (Portugal)
• Pfizer Inc. (U.S.)
• Hetero Healthcare Limited (India)
• Lumenis Ltd. (Israel)
• Baxter (U.S.)
• GALDERMA (Switzerland)
• Medicover Hospitals (India)

What are the Recent Developments in Global Pilar Cyst Treatment Market?

• In September 2025, a medical innovation was announced concerning the development of a simple thermal device to treat sebaceous cysts (often clinically grouped with pilar cysts) without surgical intervention. The device, which received a granting authority from the Saudi Authority for Intellectual Property, is designed to dissolve the sebaceous cyst and reduce its wall, offering a comfortable and effective alternative to traditional surgery. This development points toward a future non-invasive product segment in the market
• In August 2025, a new focus was placed on advanced energy-based techniques, such as CO2 laser and Plasma Exeresis, as part of the minimally invasive approach to cyst removal. The CO2 laser is used to create a small hole for the removal of cyst contents, followed by minimal excision of the wall, leading to less scarring and good cosmetic results, particularly for smaller cysts. Plasma Exeresis was also noted as an innovative technique for sebaceous cysts, which are often grouped with pilar cysts, for minimal scarring
• In May 2025, Aventus Clinic released guidelines on cyst removal aftercare, stressing the importance of keeping the wound clean and dry, changing dressings as directed, avoiding strenuous activity, and monitoring for signs of infection. These measures are crucial for promoting healing and preventing complications
• In February 2025, Medscape published an article detailing the latest surgical techniques for pilar cyst removal. The piece emphasized the importance of complete excision of the cyst and its epithelial lining to prevent recurrence. It also discussed various surgical methods, including elliptical excision and dermal punch incision, to enhance treatment outcomes
• In December 2024, a clinic specializing in laser therapy introduced a non-surgical treatment for pilar cysts. This method offers a minimally invasive approach, promising faster recovery, reduced pain, and long-lasting relief. The clinic highlighted this as a significant advancement in cyst treatment for 2025

SKU-60143